Skip to main content
Erschienen in: Herz 3/2015

01.05.2015 | Original article

Predictive value of visceral adiposity index for type 2 diabetes mellitus

A 15-year prospective cohort study

verfasst von: Y. Wang, S. He, J. He, S. Wang, K. Liu, X. Chen

Erschienen in: Herz | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The emerging term “visceral adiposity index (VAI)” was reported to be closely correlated with glycemic disturbances and diabetes risk. However, whether VAI could predict future type 2 diabetes mellitus (DM) is unknown. Here, we aimed to assess the predictive value of VAI for DM in a Chinese population via a prospective cohort study.

Patients and methods

This prospective cohort study was conducted based on a 15-year follow-up in a general Chinese population from an urban community. In all, 711 subjects underwent a health examination in 1992, and in 2007 the same examination was repeated. Twenty-four subjects were excluded from the analysis because DM was diagnosed at baseline. Waist circumference (WC), body mass index (BMI), VAI, and cardiovascular risk factors were collected at baseline. Hazard ratios (HRs) for DM incidence were estimated applying Cox proportional hazards models. Paired homogeneity tests were used to explore whether there was a statistical difference between the HRs of VAI and the other two indicators.

Results

In all, 74 individuals developed DM during a follow-up of 15 years. The risk of future DM increased with increasing levels of VAI. After adjusting for confounders, for each SD increment in natural logarithm-transformed VAI, BMI, and WC the HRs were 1.538 (95 % CI: 1.225–1.930), 1.639 (95 % CI: 1.289–2.084) and 1.858 (95 % CI: 1.458–2.369), respectively. However, paired homogeneity tests showed no statistical difference among the HRs.

Conclusion

VAI could independently predict DM in the Chinese study population, although the predictive power was not higher than that of simple anthropometric measures (BMI and WC). Our study does not support the clinical application of VAI; however, more studies based on different ethnic groups still need to be performed.
Literatur
1.
Zurück zum Zitat Levitzky YS, Pencina MJ, D’Agostino RB et al (2008) Impact of impaired fasting glucose on cardiovascular disease: the Framingham heart study. J Am Coll Cardiol 51:264–270CrossRefPubMed Levitzky YS, Pencina MJ, D’Agostino RB et al (2008) Impact of impaired fasting glucose on cardiovascular disease: the Framingham heart study. J Am Coll Cardiol 51:264–270CrossRefPubMed
2.
Zurück zum Zitat Li SC, Liu YH, Liu JF et al (2011) Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism 60(4):474–479CrossRefPubMed Li SC, Liu YH, Liu JF et al (2011) Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism 60(4):474–479CrossRefPubMed
3.
Zurück zum Zitat Wilson PW, Meigs JB, Sullivan L et al (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074CrossRefPubMed Wilson PW, Meigs JB, Sullivan L et al (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074CrossRefPubMed
4.
Zurück zum Zitat Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731CrossRefPubMed Lindstrom J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731CrossRefPubMed
5.
Zurück zum Zitat Zhou X, Qiao Q, Ji L et al (2013) Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care 36(12):3944–3952CrossRefPubMedCentralPubMed Zhou X, Qiao Q, Ji L et al (2013) Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care 36(12):3944–3952CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Bozorgmanesh M, Hadaegh F, Azizi F (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: tehran lipid and glucose study. Lipids Health Dis 9:45. doi:10.1186/1476-511X-9-45CrossRefPubMedCentralPubMed Bozorgmanesh M, Hadaegh F, Azizi F (2010) Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: tehran lipid and glucose study. Lipids Health Dis 9:45. doi:10.1186/1476-511X-9-45CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat He S, Zheng Y, Shu Y et al (2013) Hypertriglyceridemic Waist might be an alternative to metabolic syndrome for predicting future Diabetes Mellitus. PLoS One 8(9):e73292. doi:10.1371/journal.pone.0073292CrossRefPubMedCentralPubMed He S, Zheng Y, Shu Y et al (2013) Hypertriglyceridemic Waist might be an alternative to metabolic syndrome for predicting future Diabetes Mellitus. PLoS One 8(9):e73292. doi:10.1371/journal.pone.0073292CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Amato MC, Giordano C, Galia M et al (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4):920–922CrossRefPubMedCentralPubMed Amato MC, Giordano C, Galia M et al (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4):920–922CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Stepien M, Stepien A, Wlazel RN, Paradowski M et al (2014) Predictors of insulin resistance in patients with obesity: a pilot study. Angiology 65(1):22–30CrossRefPubMed Stepien M, Stepien A, Wlazel RN, Paradowski M et al (2014) Predictors of insulin resistance in patients with obesity: a pilot study. Angiology 65(1):22–30CrossRefPubMed
10.
Zurück zum Zitat Al-Daghri NM, Al-Attas OS, Alokail MS et al (2013) Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest 43(2):183–189CrossRefPubMed Al-Daghri NM, Al-Attas OS, Alokail MS et al (2013) Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest 43(2):183–189CrossRefPubMed
11.
Zurück zum Zitat Du T, Sun X, Huo R, Yu X (2013) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes (Lond) 19. doi:10.1038/ijo.2013.181 Du T, Sun X, Huo R, Yu X (2013) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes (Lond) 19. doi:10.1038/ijo.2013.181
12.
Zurück zum Zitat He S, Chen X, Cui K et al (2012) Validity evaluation of recently published diabetes risk scoring models in a general Chinese population. Diabetes Res Clin Pract 95(2):291–298CrossRefPubMed He S, Chen X, Cui K et al (2012) Validity evaluation of recently published diabetes risk scoring models in a general Chinese population. Diabetes Res Clin Pract 95(2):291–298CrossRefPubMed
13.
Zurück zum Zitat Liu K, He S, Hong B et al (2013) Over time, do anthropometric measures still predict diabetes incidence in chinese han nationality population from chengdu community? Int J Endocrinol. doi:10.1155/2013/239376 Liu K, He S, Hong B et al (2013) Over time, do anthropometric measures still predict diabetes incidence in chinese han nationality population from chengdu community? Int J Endocrinol. doi:10.1155/2013/239376
14.
Zurück zum Zitat D’Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743–753CrossRef D’Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743–753CrossRef
15.
Zurück zum Zitat Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4):361–387CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4):361–387CrossRefPubMed
16.
Zurück zum Zitat Bozorgmanesh M, Hadaegh F, Azizi F (2011) Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 10:88. doi:10.1186/1476-511X-10-88CrossRefPubMedCentralPubMed Bozorgmanesh M, Hadaegh F, Azizi F (2011) Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 10:88. doi:10.1186/1476-511X-10-88CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Ford ES, Williamson DF, Liu S (1997) Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 146(3):214–222CrossRefPubMed Ford ES, Williamson DF, Liu S (1997) Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 146(3):214–222CrossRefPubMed
18.
Zurück zum Zitat Wannamethee SG, Shaper AG, Walker M (2005) Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 59(2):134–139CrossRefPubMedCentralPubMed Wannamethee SG, Shaper AG, Walker M (2005) Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. J Epidemiol Community Health 59(2):134–139CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat O’Rahilly S, Farooqi IS (2008) Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 57(11):2905–2910CrossRef O’Rahilly S, Farooqi IS (2008) Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 57(11):2905–2910CrossRef
20.
Zurück zum Zitat Björntorp P (1991) Metabolic implications of body fat distribution. Diabetes Care 14(12):1132–1143CrossRefPubMed Björntorp P (1991) Metabolic implications of body fat distribution. Diabetes Care 14(12):1132–1143CrossRefPubMed
21.
Zurück zum Zitat Kissebah AH (1996) Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease? Diabetes Res Clin Pract 30(Suppl):25–30CrossRefPubMed Kissebah AH (1996) Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease? Diabetes Res Clin Pract 30(Suppl):25–30CrossRefPubMed
22.
Zurück zum Zitat Oh JY, Sung YA, Lee HJ (2013) The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring) 21(8):1690–1694 Oh JY, Sung YA, Lee HJ (2013) The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring) 21(8):1690–1694
Metadaten
Titel
Predictive value of visceral adiposity index for type 2 diabetes mellitus
A 15-year prospective cohort study
verfasst von
Y. Wang
S. He
J. He
S. Wang
K. Liu
X. Chen
Publikationsdatum
01.05.2015
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe Sonderheft 3/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-014-4175-1

Weitere Artikel der Sonderheft 3/2015

Herz 3/2015 Zur Ausgabe

Übersichtsarbeit

Epikardiales Fett

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.